BioCryst Pharmaceuticals





Ebitda Cambiamento Data
Alnylam Pharmaceuticals USD 145.22M 236.56M 2025-12
Chugai Pharma JPY 169.01B 12.52B 2025-12
Daiichi Sankyo JPY 101.6B 22.81B 2025-03
DBV Technologies USD -33.48M 5.55M 2025-09
Gilead Sciences USD 4.03B 628M 2025-09
GlaxoSmithKline GBP 3.36B 179M 2025-09
Glaxosmithkline GBP 4.75B 1.52B 2025-09
Incyte USD 414.5M 92.42M 2025-12
Ionis Pharmaceuticals USD -157.12M 307.36M 2025-09
Karyopharm Therapeutics USD -26.2M 1.83M 2024-09
Neurocrine Biosciences USD 218.4M 28.3M 2025-12
Novavax USD -117.12M 55.66M 2024-09
PTC Therapeutics USD 20.63M 53.74M 2025-09
Regeneron Pharmaceuticals USD 1.92B 261.9M 2025-09
Roche Holding CHF 12.68B 2.36B 2024-06
Sarepta Therapeutics USD -168.03M 294.45M 2025-09
Ultragenyx Pharmaceutical USD -156.79M 65.44M 2025-09
Vertex Pharmaceuticals USD 1.44B 100.4M 2025-09


BioCryst Pharmaceuticals - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2026.